A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.
Condition: Anemia of Chronic Kidney Disease Interventions: Drug: JTZ-951; Drug: Darbepoetin Alfa Sponsor: JW Pharmaceutical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2019 Category: Research Source Type: clinical trials
